cueFlash

Glossary of cancer

Start Studying! Add Cards ↓

Created by mehtapaulette

Deck Info

Description

Tags

Recent Users

advanced gastric cancer:systemic review

 

best resutls with 3 drug regimens:fu,anthracycine and cixlatin. bolus infsuion 5FU > toxic infusional 5FU;

CELECOXIB VS PLACEBO FOR MEN WITH PROSTATE CA.

 

78 MEN, 8 OF 40 MEN IN PLACEBO & L5 OF 38 IN CELECOXIB GROUP HAD POST TTMT PSADT (PSA DOUBLING TIME); INCREASED FOR PLACEBO GROUP, DECREASED FOR COX 2 GROUP
asco:antiemetics 2006
3 drug combination:5-OHtryptamine serotnin receptor antagonist (ondansetron) + dex + aprepitant for high risk;  aprepitant only for highly emetic;
cetuximab + cis or carboplat & fu, recurrent or meta H&N ca (scc),jco 2006,europe

cetuximab 400mg/m2;then weekly 250mg/m2.with 3 week cycles of cisplat l00mg/m2 or carbo auc5;with 5FU,5 d infusions (600,800,1000mg/m2).combination was well tolerated and effective,asco oral meeting 2004

PHASE 3 STUDY: ORAL TOPOTECAN VS DOCETAXEL (IV), PTS WITH PRETREATED ADVANCED NSC-LC; jco 2005

topotecan 2.3mg/m2/d,d l-5; or doxetaxel 75mg/2 d-1 q 21 d.829 pts, europe. 25% pts with topo, and 29% with docetaxel. thus, oral topo should be co nsidered for relapsers since it's oral and as good.

 

Add Cards

You must Login or Register to add cards